Clinical Trials List
2023-08-01 - 2028-03-15
Phase I
Not yet recruiting3
Recruiting1
ICD-10C56.1
Malignant neoplasm of right ovary
ICD-10C56.2
Malignant neoplasm of left ovary
ICD-10C56.9
Malignant neoplasm of unspecified ovary
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9183.0
Malignant neoplasm of ovary
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Jih-Hsiang Lee 無
- JIN-YUAN SHIH 無
- 許嘉林 無
- 陳宇立 無
- James Chih-Hsin Yang 無
- Chong-Jen Yu 無
- 蔡子修 無
- YEN-TING LIN 無
- YING-CHENG CHIANG 無
- 徐偉勛 無
- CHAO-CHI HO CHAO-CHI HO 無
- 楊景堯 無
- Wen-Fang Cheng 無
- CHI-HAU CHEN CHI-HAU CHEN 無
- 廖斌志 無
- 廖唯昱 無
- 吳尚俊 無
- 黃信端 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Cheng-Yang Chou 無
- 林語涵 無
- 蔡政軒 無
- 吳珮瑩 無
- Meng-Ru Shen 無
- 黃蘭茵 無
- Seu-Chun Yang 無
- Chun-Hui Lee 無
- 鄭雅敏 無
- 江佳蓉 無
- Chian-Wei Chen 無
- Keng-Fu Hsu 無
- Chien-Chung Lin 無
- Chin-Wei Kuo 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
26 participants
-
Global
1149 participants
